- Visit Columbus & Ohio State
- Commitment to Diversity
- Undergraduate Programs
- Graduate Programs
- Divisions and Centers
- Environmental Health Sciences
- Health Behavior and Health Promotion
- Health Services Management and Policy
- Health Outcomes, Policy and Evaluation Studies
- Center for Public Health Practice
- Center of Excellence in Regulatory Tobacco Science
- Apply Now
- Recruitment Calendar
- Why Public Health at Ohio State
- BSPH + MPH in 5 years
- Dual/Combined Degrees
- Undergraduate Programs
- Bachelor of Science in Public Health
- Epidemiology Minor
- Global Public Health Minor
- Graduate Programs
- Master of Public Health
- Master of Health Administration
- Master of Science
- Doctor of Philosophy
- Graduate Interdisciplinary Specialization in Global Health
- Graduate Minor in Public Health Behavior and Promotion
- Contact Us
- Student Forms and Resources
- Graduate Students
- Undergraduate Students
- Curriculum Guides
- Career Services
- Student Organizations
- Alumni Connect
- News and Events
Julie K. Bower, PhD, MPH
344 Cunz Hall
1841 Neil Ave
Columbus, OH 43210
Dr. Bower is a cardiovascular and diabetes epidemiologist with expertise in type 2 diabetes, hypertension, lifestyle risk factors and health disparities. Her research program focuses on the epidemiology of diabetes and cardiovascular diseases; biological pathways through which lifestyle behaviors influence metabolic factors; vascular complications of diabetes; and the role of race and ethnicity in disease pathogenesis and distribution.
NHLBI Postdoctoral Fellowship in Cardiovascular Epidemiology, Johns Hopkins Bloomberg School of Public Health, 2010-2013
PhD, Epidemiology, University of Minnesota, 2010
MPH, Health Behavior and Health Education, University of North Carolina at Chapel Hill, 2006
BS, Health Sciences, James Madison University, 2000
PUBHEPI 6410: Principles of Epidemiology
PUBHEPI 8430: Epidemiology IV
PUBHEPI 8899.03: Introductory Doctoral Seminar in Epidemiology
Park K, Cho S, Bower JK. “Changes in adherence to non-pharmacological guidelines for hypertension,” PLOSOne. 2016; 11(8), e0161712.
Fyfe-Johnson AL, Alonso A, Selvin E, Bower JK, Pankow JS, Agarwal SK, Lutsey PL. “Serum fibroblast growth factor-23 and incident hypertension: the Atherosclerosis Risk in Communities Study,” Journal of Hypertension. 2016. 34(7), 1266-1272.
Bower JK, Lazo M, Matsushita K, Rubin J, Hoogeveen RC, Ballantyne CM, Selvin E. “N-terminal pro-brain natriuretic peptide (NT-proBNP) and risk of hypertension in the Atherosclerosis Risk in Communities (ARIC) Study,” American Journal of Hypertension. 2015; doi: 10.1093/ajh/hpv026.
Kite B, Tangasi W, Kelley M, Bower JK, Foraker RE. “Electronic Medical Records and their use in health promotion and population research of cardiovascular disease,” Current Cardiovascular Risk Reports. 2015; 9, 422-429.
Juraschek SP, Bower JK, Selvin E, Shantha GPS, Hoogeveen RC, Ballantyne CM, Young JH. “Plasma lactate and incident hypertension in the Atherosclerosis Risk in Communities Study,” American Journal of Hypertension. 2014; 28(2), 216-224.
Varma R, Bressler NM, Doan QV, Gleeson M, Danese M, Bower JK, Selvin E, Dolan C, Fine J, Colman S, Turpcu A. “Prevalence of and risk factors for diabetic macular edema in the United States,” JAMA Opthalmology. 2014; 132(11): 1334-1340.
Park Y, Ko S, Lee J, Han K, Song SJ, Kang SW, Bower JK, Ahn Y. “Glycaemic and haemoglobin A1c thresholds for detecting diabetic retinopathy: the fifth Korea National Health and Nutrition Examination Survey (2011),” Diabetes Research and Clinical Practice. 2014; 104(3), 435-442.
Bower JK, Pankow JS, Lazo M, Christenson E, Hoogeveen RC, Ballantyne CM, Halushka MK, Astor BC, Selvin E. “Three-year variability in plasma concentrations of the soluble receptor for advanced glycation end products (sRAGE),” Clinical Biochemistry. 2014; 47, 132-134.
Bressler NM, Varma R, Doan QV, Gleeson M, Danese M, Bower JK, Selvin E, Dolan C, Fine J, Turpcu A. “Underuse of the health care system by persons with diabetes mellitus and diabetic macular edema in the United States,” JAMA Opthalmology. 2014; 132(2): 168-173.
Carson AP, Lewis CE, Jacobs DR, Peralta CA, Steffen LM, Bower JK, Person SD, Muntner P. “Evaluating the Framingham hypertension risk prediction model in young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study,” Hypertension, 2013; 62(6), 1015-1020.
Bower, JK, Brancati FL, Selvin E. “No ethnic differences in the association of glycated hemoglobin with retinopathy: the National Health and Nutrition Examination Survey 2005-2008,” Diabetes Care, 2013; 36(3), 569-573.
Bower JK, Lazo M, Juraschek SP, Selvin E. “Within-person variability in high-sensitivity C-reactive protein,” Archives of Internal Medicine, 2012; 172(19), 1519-1521.
Sherwood A, Bower JK, Routledge FS, Blumenthal JA, McFetridge-Durdle JA, Newby LK, Hinderliter AL. “Nighttime blood pressure dipping in postmenopausal women with coronary heart disease,” American Journal of Hypertension, 2012; 25(20), 1077-1082.
Bower JK, Appel LJ, Matsushita K, Young JH, Alonso A, Brancati FL, Selvin E. “Glycated hemoglobin and risk of hypertension in the Atherosclerosis Risk and Communities (ARIC) Study,” Diabetes Care, 2012; 35(5), 1031-1037.